treating cells with the compounds led to enhanced autophagic clearance of proteins other than mHTT. Li et al. assessed the levels of the repertoire of proteins in the cortices of mice that carried an mHtt allele. They found changes in the abundance of a small percentage of proteins in mice treated with the compounds, compared with untreated animals. What remains unclear is whether the levels of some proteins decreased because mHTT levels were diminished, or because of autophagy. Modest changes in protein-expression level (in the 20-30% range for some wild-type proteins) can cause neurological deficits 8 , so pinpointing any off-target effects of the compounds will be a crucial next step. Even effects that initially seem inconsequential might build up over the course of long-term therapy, becoming as problematic decades later as the original toxic protein.
Despite these concerns, the authors found encouraging evidence that the compounds could produce functional improvements in models of Huntington's disease across three species. First, patient-derived neurons treated with each of the compounds showed significantly less shrinkage, degeneration of neuronal projections and cell death than was seen in untreated neurons. Second, flies that model Huntington's disease and were treated with the compounds recovered climbing ability and survived longer than did untreated counterparts. Third, treated mice that model Huntington's disease showed improvements in three motor tests, compared with untreated mice. That said, preclinical trials in mice will be necessary to ascertain that the benefit is sustained and robust over the course of long-term therapy.
Finally, Li et al. analysed mutant ataxin-3, a protein that is involved in a neurodegenerative disorder called spino-cerebellar ataxia type 3. The researchers found that the compounds targeted the long polyglutamine tract of mutant ataxin-3 and lowered protein levels. We already know that small reductions in the levels of mutant ataxin-1, ataxin-2 and ataxin-3 can reduce the severity of spino-cerebellar ataxia types 1, 2 and 3, respectively, in mouse models [9] [10] [11] . Thus, this therapeutic strategy might be useful not only for Huntington's disease, but also for other diseases involving expanded polyglutamine tracts.
Moving forwards, there are three major research paths to pursue. The first involves establishing the mechanism by which Li and colleagues' compounds recognize proteins with expanded polyglutamine tracts but spare normal proteins. Perhaps the compounds recognize a particular structural conformation that arises only after the polyglutamine tract exceeds a specific length. The second involves testing the compounds in other models of polyglutamine disorders and assessing their effects.
The third path involves conducting similar small-molecule screens for compounds that can clear polyglutamine proteins using other types of protein-clearance machinery. For instance, small molecules dubbed proteo lysistargeting chimaeras (PROTACs) link a ubiquitin ligase enzyme to a protein of interest. The enzyme tags the protein with ubiquitin groups, leading to the protein's degradation by a cellular machine called the proteasome 12 .
PROTACs have yet to be applied to a poly glutamineexpanded protein. But given that some of these proteins are degraded by the proteasome, the strategy could well prove viable -as long as it targets only the abnormally long polyglutamine tract. In science-fiction films, robots are often depicted as human-sized or larger machines made of rigid materials. However, robots made of soft materials or with flexible structures, and that can be much smaller than the human body, have attracted great interest in the past few years because they have the potential to interact with humans more safely than can rigid machines. Indeed, sufficiently small soft robots could even be used for biomedical applications in the human body. Various options are available to power these robots, but magnetic fields offer a safe and effective means of wireless operation in confined spaces in the body. On page 164, Cui et al. 1 report a key step towards the fabrication of micrometre-scale robots that, in a programmable manner, can quickly morph into different shapes in applied magnetic fields.
The ability of minerals known as lodestones to align with Earth's magnetic field was first reported in the ancient Chinese manuscripts Gui Gu Zi and Han Fei Zi, and was later used in early magnetic compasses 2 . A similar principle has been used in the past few years in magnetic soft robots 3-10 , in which magnets of varying sizes (nanometres to millimetres) are integrated into flexible structures or soft materials. The tendency of the magnets to orient in externally applied magnetic fields provides a way of quickly moving or changing the shape of these untethered robots remotely. This actuation mechanism allows much flexibility in the design of the robots' structures, magnetization patterns and strengths, and in when and where magnetic fields are applied to control the robots. In addition, because the forces and torques exerted on magnets by external magnetic fields can be accurately calculated, models have been developed to quantitatively describe the actuation of specific robot designs 11 .
Magnetic soft robots have been developed for various uses, especially in biomedical applications in which they interact closely with the human body. For example, self-folding 'origami' robots have been reported that can crawl through the gut, patch wounds and dislodge swallowed objects 4 ; and capsule-shaped robots have been made that roll along the inner surface of the stomach and can perform biopsies and deliver medicine 3 . Magnetically steerable robotic catheters have also been developed, which can perform minimally
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Arrays of nanoscale magnets have been constructed to form the magnetized panels of microscopic robots -thus allowing magnetic fields to be used to control the robots' shape and movement. See p.164 invasive surgery on the heart or inspect lung airways 5, 7 . And much thinner, thread-like robots have been made that could potentially navigate the brain's blood vessels to treat strokes or aneurysms 10 . These robots range in size from hundreds of micrometres to a few centimetres in diameter.
Further miniaturization of magnetic soft robots could enable new applications, such as performing operations in the smallest blood vessels and manipulating single cells, but the fabrication of such tiny machines poses a considerable challenge. Existing methods for the construction of small magnetic soft robots have included the direct assembly of magnetic components [3] [4] [5] 7 , the magnetization of particle-loaded polymer sheets 6 , and the printing of soft composite materials that contain aligned magnetic particles 9,10 . Cui and colleagues now push the technological boundaries further, by using a technique called electron-beam lithography to make magnetically reconfigurable robots at scales of just a few micrometres. More specifically, this technique enables them to prepare arrays of nanoscale cobalt magnets in panels on a thin, flexible substrate of silicon nitride (Si 3 N 4 ).
The authors' cobalt nanomagnets can retain their magnetism after exposure to an external magnetic field. This behaviour is called hysteresis, and results, in part, from the nanomagnets' shape. The authors could therefore tune the nanomagnets' magnetic properties and hysteretic behaviour so that thinner nano magnets were harder to magnetize than thicker ones; in other words, stronger magnetic fields were required to magnetize thinner nano magnets. This, in turn, meant that it was easier to re-magnetize thicker magnets -to 'over-write' the strength and direction of their magnetization -using relatively weak fields.
Cui and colleagues could therefore selectively tune the magnetization of the nano magnets so that an actuating magnetic field (much weaker than the fields that initially magnetized them) caused different panels to fold in different ways. The resulting multi-panelled components were thus 'programmed' to morph into specific configurations in an actuating magnetic field (Fig. 1) . These components could, in turn, be assembled to produce complex shapes, such as letters, and even to make a microscopic 'bird' that produces motions such as turning, flapping and slipping across a surface.
Much work must still be done to achieve the full potential of magnetic soft robots for biomedical applications across various length scales. They must be designed using quantitative models to optimize their performance for specific tasks in relatively weak magnetic fields -that is, to work out which reconfigurations are needed, the sizes of the forces that the robot must exert on its environment, and the speeds at which reconfigurations should occur and with which the forces should be applied. Advanced fabrication platforms, such as the one used by Cui et al., will be crucial for implementing future designs.
Methods for the real-time imaging and localization of robots deep in the human body are also needed, particularly in tight spaces, and must not interfere with the magnetic-actuation mechanisms. Artificial intelligence might be further developed to assist image analysis and robot control. Lastly, methods are needed for the safe retrieval or degradation of robots once they have performed their tasks. Degradation without toxicity or other adverse effects is particularly desirable. Magnetic soft robots are also being extensively studied for applications beyond biomedicine 8 , such as in flexible electronics, reconfigurable surfaces and active metamaterials (engineered materials consisting of subunits that take in energy locally, and then translate it into movement that can produce large-scale dynamic motion). A parallel set of platforms for the design, fabrication, imaging and control of magnetic soft robots across various length scales are therefore under development. That work, together with developments such as those of Cui and colleagues, is laying the foundation for this nascent field.
